Back to News
Market Impact: 0.1
DEA Burden of Proof, Missing Rulebooks, and Expert Witness Admissions Threaten Marijuana Rescheduling
Source: Newswire
Regulation & LegislationHealthcare & Biotech
MMJ International Holdings CEO Duane Boise said the burden of proof in marijuana rescheduling rests with the government. He claimed a government DEA and FDA scientist said marijuana would not have passed the test, and that a government watchdog found no written rulebook; no further details or market reaction were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
More News
- With earnings in rearview mirror, SpaceX-Tesla merger chatter takes center stage
- Looters hit 3,000 French businesses. Within hours, the haul was trending on Vinted under the riot’s date
- The real test for Moderna’s cancer vaccine isn’t about beating Keytruda. It’s keeping cancer from coming back in the long term.
- Oncologists Cheer Melanoma Data
- Vertex reports positive IgAN trial data, FDA decision due Nov. 30
- OpenAI disables internet access during model training while Anthropic issues another mea culpa